Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 23584809)

1.

Effects of recombinant human erythropoietin on resistance artery endothelial function in stage 4 chronic kidney disease.

Briet M, Barhoumi T, Mian MO, Sierra C, Boutouyrie P, Davidman M, Bercovitch D, Nessim SJ, Frisch G, Paradis P, Lipman ML, Schiffrin EL.

J Am Heart Assoc. 2013 Apr 12;2(2):e000128. doi: 10.1161/JAHA.113.000128.

3.

Renovascular protective effects of erythropoietin in patients with chronic kidney disease.

Fujiwara N, Nakamura T, Sato E, Kawagoe Y, Hikichi Y, Ueda Y, Node K.

Intern Med. 2011;50(18):1929-34. Epub 2011 Sep 15.

4.

Impaired endothelial function in isolated human uremic resistance arteries.

Morris ST, McMurray JJ, Spiers A, Jardine AG.

Kidney Int. 2001 Sep;60(3):1077-82.

5.

Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Martí-Carvajal AJ, Agreda-Pérez LH, Solà I, Simancas-Racines D.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD000332. doi: 10.1002/14651858.CD000332.pub3. Review.

PMID:
23450527
6.

Epoetin-alpha: preserving kidney function via attenuation of polymorphonuclear leukocyte priming.

Kristal B, Shurtz-Swirski R, Tanhilevski O, Shapiro G, Shkolnik G, Chezar J, Snitkovsky T, Cohen-Mazor M, Sela S.

Isr Med Assoc J. 2008 Apr;10(4):266-72.

7.

Human recombinant erythropoietin alters the flow-dependent vasodilatation of in vitro perfused rat mesenteric arteries with unbalanced endothelial endothelin-1 / nitric oxide ratio.

Barhoumi T, Jallat I, Berthelot A, Laurant P.

Can J Physiol Pharmacol. 2011 Jun;89(6):435-43. doi: 10.1139/y11-032. Epub 2011 Jul 21.

PMID:
21777087
8.

Lack of prognostic role of endothelial dysfunction in subcutaneous small resistance arteries of hypertensive patients.

Rizzoni D, Porteri E, De Ciuceis C, Boari GE, Zani F, Miclini M, Paiardi S, Tiberio GA, Giulini SM, Muiesan ML, Castellano M, Rosei EA.

J Hypertens. 2006 May;24(5):867-73.

PMID:
16612248
9.

Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.

Amiri F, Ko EA, Javeshghani D, Reudelhuber TL, Schiffrin EL.

J Hypertens. 2010 Jun;28(6):1243-51. doi: 10.1097/HJH.0b013e328338bb8b.

PMID:
20308920
10.

The influence of erythropoietin on the vascular responses of rat resistance arteries.

Wu XC, Richards NT, Johns EJ.

Exp Physiol. 1999 Sep;84(5):917-27.

11.

Effects of anemia correction by erythropoiesis-stimulating agents on cardiovascular function in non-dialysis patients with chronic kidney disease.

Suzuki M, Hada Y, Akaishi M, Hiroe M, Aonuma K, Tsubakihara Y, Akizawa T.

Int Heart J. 2012;53(4):238-43.

12.

Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids.

Bode-Böger SM, Böger RH, Kuhn M, Radermacher J, Frölich JC.

Kidney Int. 1996 Oct;50(4):1255-61.

PMID:
8887285
13.

Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.

Guerrero-Riscos MÁ, Montes-Delgado R, Seda-Guzmán M, Praena-Fernández JM.

Nefrologia. 2012 May 14;32(3):343-52. doi: 10.3265/Nefrologia.pre2012.Jan.11111. Epub 2012 Apr 17. English, Spanish.

14.
15.

Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin.

d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS.

Hypertension. 2007 May;49(5):1142-8. Epub 2007 Mar 19.

16.

Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.

Pérez-Oliva JF, Casanova-González M, García-García I, Porrero-Martín PJ, Valenzuela-Silva CM, Hernández-Montero T, Lagarde-Ampudia M, Casanova-Kutsareva Y, Avila-Albuerne Y, Vargas-Batista A, Bobillo-López H, Herrera-Valdés R, López-Saura PA; Bioequivalence Study of Erythropoietin Group.

BMC Nephrol. 2005 May 23;6:5.

17.

Renal anemia: from incurable to curable.

Sato Y, Yanagita M.

Am J Physiol Renal Physiol. 2013 Nov 1;305(9):F1239-48. doi: 10.1152/ajprenal.00233.2013. Epub 2013 Jul 24. Review.

19.

Influence of erythropoietin on arterial stiffness and endothelial function in renal transplant recipients.

Bartels V, Hillebrand U, Kosch M, Hausberg M, Kisters K, Di Marco GS, Reiermann S, Pavenstaedt H, Lang D.

Am J Nephrol. 2012;36(4):355-61. doi: 10.1159/000343140. Epub 2012 Oct 4.

PMID:
23038220
20.

Epoetin alfa and darbepoetin alfa: effects on ventricular hypertrophy in patients with chronic kidney disease.

Chen HH, Tarng DC, Lee KF, Wu CY, Chen YC.

J Nephrol. 2008 Jul-Aug;21(4):543-9.

PMID:
18651544
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk